fanta.bio Sample: CNhs10844
25217 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 994 / 8871 (11.2%) | 247 / 88710 (0.3%) | −324.0 | −324.0 | 40.24 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1394 / 8871 (15.7%) | 446 / 88710 (0.5%) | −324.0 | −324.0 | 31.26 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1339 / 8871 (15.1%) | 441 / 88710 (0.5%) | −324.0 | −324.0 | 30.36 |
| HIF1A SRX11007095 | HK-2 Kidney | 1687 / 8871 (19.0%) | 567 / 88710 (0.6%) | −324.0 | −324.0 | 29.75 |
| TP53 SRX19538279 | Osteoblasts Bone | 453 / 8871 (5.1%) | 163 / 88710 (0.2%) | −324.0 | −324.0 | 27.79 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1853 / 8871 (20.9%) | 674 / 88710 (0.8%) | −324.0 | −324.0 | 27.49 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1773 / 8871 (20.0%) | 656 / 88710 (0.7%) | −324.0 | −324.0 | 27.03 |
| SCML2 SRX644728 | 293 Kidney | 1064 / 8871 (12.0%) | 447 / 88710 (0.5%) | −324.0 | −324.0 | 23.80 |
| FOXP1 SRX736067 | LNCAP Prostate | 1450 / 8871 (16.3%) | 692 / 88710 (0.8%) | −324.0 | −324.0 | 20.95 |
| MYH11 SRX265221 | ME-1 Blood | 664 / 8871 (7.5%) | 352 / 88710 (0.4%) | −324.0 | −324.0 | 18.86 |
| BRD4 SRX9419935 | BT-474 Breast | 2303 / 8871 (26.0%) | 1732 / 88710 (2.0%) | −324.0 | −324.0 | 13.30 |
| MED1 SRX9419945 | BT-474 Breast | 2297 / 8871 (25.9%) | 1753 / 88710 (2.0%) | −324.0 | −324.0 | 13.10 |
| BRD4 SRX9419937 | BT-474 Breast | 2310 / 8871 (26.0%) | 1766 / 88710 (2.0%) | −324.0 | −324.0 | 13.08 |
| MED1 SRX9419946 | BT-474 Breast | 2336 / 8871 (26.3%) | 1799 / 88710 (2.0%) | −324.0 | −324.0 | 12.98 |
| MED1 SRX9419944 | BT-474 Breast | 2236 / 8871 (25.2%) | 1743 / 88710 (2.0%) | −324.0 | −324.0 | 12.83 |
| BRD4 SRX9419936 | BT-474 Breast | 2341 / 8871 (26.4%) | 1838 / 88710 (2.1%) | −324.0 | −324.0 | 12.74 |
| BRD4 SRX9419938 | BT-474 Breast | 2305 / 8871 (26.0%) | 1830 / 88710 (2.1%) | −324.0 | −324.0 | 12.60 |
| MED1 SRX9419947 | BT-474 Breast | 2242 / 8871 (25.3%) | 1782 / 88710 (2.0%) | −324.0 | −324.0 | 12.58 |
| BRD4 SRX736201 | 90-8TL Neural | 4005 / 8871 (45.1%) | 3762 / 88710 (4.2%) | −324.0 | −324.0 | 10.65 |
| EZH2 SRX2146136 | LNCAP Prostate | 4908 / 8871 (55.3%) | 4664 / 88710 (5.3%) | −324.0 | −324.0 | 10.52 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1284 / 8871 (14.5%) | 1520 / 88710 (1.7%) | −324.0 | −324.0 | 8.45 |
| TP53 SRX19538268 | U2OS Bone | 393 / 8871 (4.4%) | 90 / 88710 (0.1%) | −316.8 | −313.6 | 43.67 |
| TP53 SRX19538274 | U2OS Bone | 382 / 8871 (4.3%) | 92 / 88710 (0.1%) | −304.8 | −301.6 | 41.52 |
| TP53 SRX19538276 | U2OS Bone | 381 / 8871 (4.3%) | 105 / 88710 (0.1%) | −295.4 | −292.3 | 36.29 |
| TP53 SRX19538267 | U2OS Bone | 342 / 8871 (3.9%) | 77 / 88710 (0.1%) | −276.3 | −273.2 | 44.42 |
| TP53 SRX19538280 | Osteoblasts Bone | 365 / 8871 (4.1%) | 114 / 88710 (0.1%) | −274.8 | −271.7 | 32.02 |
| TP53 SRX19538273 | U2OS Bone | 341 / 8871 (3.8%) | 82 / 88710 (0.1%) | −272.0 | −268.9 | 41.59 |
| TP53 SRX19538281 | Osteoblasts Bone | 382 / 8871 (4.3%) | 155 / 88710 (0.2%) | −268.5 | −265.4 | 24.65 |
| HIF1A SRX20663235 | HK-2 Kidney | 372 / 8871 (4.2%) | 160 / 88710 (0.2%) | −257.0 | −253.9 | 23.25 |
| TP53 SRX19538275 | U2OS Bone | 333 / 8871 (3.8%) | 103 / 88710 (0.1%) | −251.2 | −248.2 | 32.33 |
| TP53 SRX19538269 | U2OS Bone | 403 / 8871 (4.5%) | 239 / 88710 (0.3%) | −250.2 | −247.2 | 16.86 |
| IRF3 SRX11453858 | Hep G2 Liver | 283 / 8871 (3.2%) | 41 / 88710 (0.0%) | −245.9 | −242.9 | 69.02 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 341 / 8871 (3.8%) | 126 / 88710 (0.1%) | −245.9 | −242.9 | 27.06 |
| TP53 SRX19538270 | U2OS Bone | 391 / 8871 (4.4%) | 239 / 88710 (0.3%) | −240.0 | −237.0 | 16.36 |
| IRF3 SRX11453861 | Hep G2 Liver | 262 / 8871 (3.0%) | 41 / 88710 (0.0%) | −225.0 | −222.1 | 63.90 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 838 / 8871 (9.4%) | 1987 / 88710 (2.2%) | −220.2 | −217.3 | 4.22 |
| TP53 SRX19538282 | Osteoblasts Bone | 332 / 8871 (3.7%) | 167 / 88710 (0.2%) | −218.2 | −215.2 | 19.88 |
| BRD4 SRX736204 | 90-8TL Neural | 722 / 8871 (8.1%) | 1482 / 88710 (1.7%) | −217.1 | −214.2 | 4.87 |
| TP53 SRX19538271 | U2OS Bone | 509 / 8871 (5.7%) | 660 / 88710 (0.7%) | −215.8 | −212.8 | 7.71 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 462 / 8871 (5.2%) | 510 / 88710 (0.6%) | −215.5 | −212.6 | 9.06 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 649 / 8871 (7.3%) | 1190 / 88710 (1.3%) | −214.7 | −211.8 | 5.45 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 438 / 8871 (4.9%) | 558 / 88710 (0.6%) | −187.4 | −184.5 | 7.85 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 404 / 8871 (4.6%) | 499 / 88710 (0.6%) | −176.1 | −173.2 | 8.10 |
| KAT6A SRX20971022 | Fibroblasts Others | 218 / 8871 (2.5%) | 50 / 88710 (0.1%) | −175.3 | −172.4 | 43.60 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 902 / 8871 (10.2%) | 2814 / 88710 (3.2%) | −172.1 | −169.3 | 3.21 |
| PBX4 SRX2731658 | PC-3 Prostate | 488 / 8871 (5.5%) | 13627 / 88710 (15.4%) | −171.6 | −168.7 | 0.36 |
| AR SRX10820653 | LNCAP Prostate | 253 / 8871 (2.9%) | 120 / 88710 (0.1%) | −169.3 | −166.5 | 21.08 |
| TP53 SRX19538272 | U2OS Bone | 429 / 8871 (4.8%) | 619 / 88710 (0.7%) | −169.0 | −166.2 | 6.93 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 212 / 8871 (2.4%) | 57 / 88710 (0.1%) | −165.0 | −162.1 | 37.19 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 785 / 8871 (8.8%) | 2278 / 88710 (2.6%) | −163.6 | −160.8 | 3.45 |
| AGO2 SRX4708039 | Hep G2 Liver | 1084 / 8871 (12.2%) | 3997 / 88710 (4.5%) | −163.3 | −160.5 | 2.71 |
| 5-mC SRX882970 | LNCAP Prostate | 1692 / 8871 (19.1%) | 8126 / 88710 (9.2%) | −160.1 | −157.3 | 2.08 |
| Epitope tags SRX10549776 | K-562 Blood | 858 / 8871 (9.7%) | 2774 / 88710 (3.1%) | −155.6 | −152.8 | 3.09 |
| FOXA1 SRX4815198 | MCF-7 Breast | 473 / 8871 (5.3%) | 12781 / 88710 (14.4%) | −152.7 | −149.9 | 0.37 |
| 5-mC SRX882968 | LNCAP Prostate | 1659 / 8871 (18.7%) | 8069 / 88710 (9.1%) | −152.1 | −149.3 | 2.06 |
| AR SRX10820651 | LNCAP Prostate | 257 / 8871 (2.9%) | 178 / 88710 (0.2%) | −149.9 | −147.1 | 14.44 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 322 / 8871 (3.6%) | 360 / 88710 (0.4%) | −148.7 | −145.9 | 8.94 |
| STAT5B SRX831881 | CD8+ T cells Blood | 203 / 8871 (2.3%) | 82 / 88710 (0.1%) | −142.6 | −139.9 | 24.76 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 307 / 8871 (3.5%) | 9821 / 88710 (11.1%) | −141.1 | −138.4 | 0.31 |
| FOXA1 SRX176862 | MCF-7 Breast | 163 / 8871 (1.8%) | 7327 / 88710 (8.3%) | −140.9 | −138.2 | 0.22 |
| FOXA1 SRX4815197 | MCF-7 Breast | 348 / 8871 (3.9%) | 10453 / 88710 (11.8%) | −140.4 | −137.7 | 0.33 |
| ESR1 SRX7624157 | MCF-7 Breast | 369 / 8871 (4.2%) | 10769 / 88710 (12.1%) | −139.9 | −137.2 | 0.34 |
| FOXA1 SRX3931044 | MCF-7 Breast | 300 / 8871 (3.4%) | 9668 / 88710 (10.9%) | −139.8 | −137.1 | 0.31 |
| NFYB SRX16608147 | HeLa Uterus | 206 / 8871 (2.3%) | 95 / 88710 (0.1%) | −139.1 | −136.4 | 21.68 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 231 / 8871 (2.6%) | 8470 / 88710 (9.5%) | −138.4 | −135.7 | 0.27 |
| 5-mC SRX882965 | LNCAP Prostate | 1363 / 8871 (15.4%) | 6336 / 88710 (7.1%) | −135.3 | −132.6 | 2.15 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 147 / 8871 (1.7%) | 6842 / 88710 (7.7%) | −134.6 | −131.9 | 0.21 |
| FOXA1 SRX176863 | MCF-7 Breast | 156 / 8871 (1.8%) | 7005 / 88710 (7.9%) | −134.3 | −131.6 | 0.22 |
| ESR1 SRX4367193 | MCF-7 Breast | 499 / 8871 (5.6%) | 12515 / 88710 (14.1%) | −133.8 | −131.1 | 0.40 |
| ESR1 SRX20282961 | MCF-7 Breast | 167 / 8871 (1.9%) | 7163 / 88710 (8.1%) | −132.7 | −130.0 | 0.23 |
| BMI1 SRX644729 | 293 Kidney | 189 / 8871 (2.1%) | 79 / 88710 (0.1%) | −131.5 | −128.8 | 23.92 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 199 / 8871 (2.2%) | 7647 / 88710 (8.6%) | −129.6 | −126.9 | 0.26 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 400 / 8871 (4.5%) | 749 / 88710 (0.8%) | −129.0 | −126.3 | 5.34 |
| GATA3 SRX190239 | MCF-7 Breast | 209 / 8871 (2.4%) | 7786 / 88710 (8.8%) | −128.5 | −125.9 | 0.27 |
| FOXA1 SRX371483 | MCF-7 Breast | 150 / 8871 (1.7%) | 6698 / 88710 (7.6%) | −127.6 | −125.0 | 0.22 |
| ESR1 SRX371469 | MCF-7 Breast | 135 / 8871 (1.5%) | 6412 / 88710 (7.2%) | −127.5 | −124.9 | 0.21 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 155 / 8871 (1.7%) | 6775 / 88710 (7.6%) | −126.9 | −124.3 | 0.23 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 303 / 8871 (3.4%) | 398 / 88710 (0.4%) | −126.8 | −124.2 | 7.61 |
| FOXA1 SRX1161177 | MCF-7 Breast | 134 / 8871 (1.5%) | 6363 / 88710 (7.2%) | −126.5 | −123.9 | 0.21 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 209 / 8871 (2.4%) | 7651 / 88710 (8.6%) | −124.1 | −121.5 | 0.27 |
| ESR1 SRX371478 | MCF-7 Breast | 186 / 8871 (2.1%) | 7188 / 88710 (8.1%) | −122.1 | −119.5 | 0.26 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 183 / 8871 (2.1%) | 7127 / 88710 (8.0%) | −121.8 | −119.2 | 0.26 |
| FOXA1 SRX371481 | MCF-7 Breast | 144 / 8871 (1.6%) | 6401 / 88710 (7.2%) | −121.2 | −118.6 | 0.22 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 391 / 8871 (4.4%) | 768 / 88710 (0.9%) | −121.0 | −118.4 | 5.09 |
| RUNX1 SRX2513054 | 293 Kidney | 1749 / 8871 (19.7%) | 9535 / 88710 (10.7%) | −120.3 | −117.7 | 1.83 |
| ESR1 SRX371470 | ZR-75-1 Breast | 125 / 8871 (1.4%) | 6009 / 88710 (6.8%) | −120.2 | −117.6 | 0.21 |
| ESR1 SRX371471 | ZR-75-1 Breast | 154 / 8871 (1.7%) | 6548 / 88710 (7.4%) | −120.0 | −117.4 | 0.24 |
| FOXA1 SRX1161176 | MCF-7 Breast | 135 / 8871 (1.5%) | 6122 / 88710 (6.9%) | −117.6 | −115.0 | 0.22 |
| FOS SRX150477 | MCF 10A Breast | 380 / 8871 (4.3%) | 10156 / 88710 (11.4%) | −116.8 | −114.2 | 0.37 |
| ESR1 SRX20282960 | MCF-7 Breast | 169 / 8871 (1.9%) | 6718 / 88710 (7.6%) | −116.6 | −114.0 | 0.25 |
| FOXA1 SRX100454 | T-47D Breast | 192 / 8871 (2.2%) | 7125 / 88710 (8.0%) | −116.5 | −113.9 | 0.27 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 139 / 8871 (1.6%) | 6155 / 88710 (6.9%) | −116.1 | −113.6 | 0.23 |
| FOXA1 SRX371482 | MCF-7 Breast | 225 / 8871 (2.5%) | 7646 / 88710 (8.6%) | −115.2 | −112.7 | 0.29 |
| ESR1 SRX371467 | MCF-7 Breast | 153 / 8871 (1.7%) | 6374 / 88710 (7.2%) | −114.8 | −112.2 | 0.24 |
| CDK9 SRX7366781 | MCF-7 Breast | 170 / 8871 (1.9%) | 80 / 88710 (0.1%) | −114.1 | −111.6 | 21.25 |
| ESR1 SRX176861 | MCF-7 Breast | 262 / 8871 (3.0%) | 8218 / 88710 (9.3%) | −114.0 | −111.4 | 0.32 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 163 / 8871 (1.8%) | 68 / 88710 (0.1%) | −113.5 | −111.0 | 23.97 |
| ESR1 SRX7624156 | MCF-7 Breast | 254 / 8871 (2.9%) | 8067 / 88710 (9.1%) | −113.4 | −110.8 | 0.31 |
| YAP1 SRX757325 | H2052 Lung | 416 / 8871 (4.7%) | 10560 / 88710 (11.9%) | −113.1 | −110.6 | 0.39 |
| CDK9 SRX7366783 | MCF-7 Breast | 172 / 8871 (1.9%) | 87 / 88710 (0.1%) | −112.8 | −110.3 | 19.77 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 100 / 8871 (1.1%) | 5296 / 88710 (6.0%) | −112.4 | −109.9 | 0.19 |
| FOXA1 SRX1161173 | MCF-7 Breast | 113 / 8871 (1.3%) | 5553 / 88710 (6.3%) | −112.3 | −109.8 | 0.20 |
| ESR1 SRX371479 | MCF-7 Breast | 136 / 8871 (1.5%) | 5983 / 88710 (6.7%) | −112.2 | −109.7 | 0.23 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 132 / 8871 (1.5%) | 5871 / 88710 (6.6%) | −110.9 | −108.4 | 0.22 |
| ESR1 SRX194569 | MCF-7 Breast | 157 / 8871 (1.8%) | 6327 / 88710 (7.1%) | −110.7 | −108.2 | 0.25 |
| KAT7 SRX101303 | RKO Digestive tract | 756 / 8871 (8.5%) | 2805 / 88710 (3.2%) | −110.6 | −108.1 | 2.70 |
| BRD1 SRX286203 | RKO Digestive tract | 661 / 8871 (7.5%) | 2244 / 88710 (2.5%) | −110.6 | −108.1 | 2.95 |
| ESR1 SRX176860 | MCF-7 Breast | 269 / 8871 (3.0%) | 8215 / 88710 (9.3%) | −110.5 | −108.0 | 0.33 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1132 / 8871 (12.8%) | 5269 / 88710 (5.9%) | −110.3 | −107.8 | 2.15 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 144 / 8871 (1.6%) | 6063 / 88710 (6.8%) | −109.9 | −107.4 | 0.24 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 137 / 8871 (1.5%) | 5929 / 88710 (6.7%) | −109.6 | −107.1 | 0.23 |
| ESR1 SRX20282939 | MCF-7 Breast | 179 / 8871 (2.0%) | 6672 / 88710 (7.5%) | −109.2 | −106.8 | 0.27 |
| ETS1 SRX3033231 | HEYA8 Gonad | 202 / 8871 (2.3%) | 169 / 88710 (0.2%) | −108.4 | −106.0 | 11.95 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 131 / 8871 (1.5%) | 5765 / 88710 (6.5%) | −107.9 | −105.4 | 0.23 |
| ESR1 SRX371476 | MCF-7 Breast | 106 / 8871 (1.2%) | 5286 / 88710 (6.0%) | −107.9 | −105.4 | 0.20 |
| ESR1 SRX1531791 | MCF-7 Breast | 149 / 8871 (1.7%) | 6078 / 88710 (6.9%) | −107.2 | −104.8 | 0.25 |
| FOXA1 SRX1161174 | MCF-7 Breast | 160 / 8871 (1.8%) | 6258 / 88710 (7.1%) | −106.7 | −104.3 | 0.26 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 139 / 8871 (1.6%) | 40 / 88710 (0.0%) | −106.6 | −104.2 | 34.75 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 369 / 8871 (4.2%) | 9624 / 88710 (10.8%) | −106.5 | −104.1 | 0.38 |
| YAP1 SRX5718140 | 293 Kidney | 279 / 8871 (3.1%) | 8242 / 88710 (9.3%) | −106.5 | −104.0 | 0.34 |
| FOXA1 SRX1787653 | MCF-7 Breast | 114 / 8871 (1.3%) | 5394 / 88710 (6.1%) | −106.3 | −103.8 | 0.21 |
| ESR1 SRX371468 | MCF-7 Breast | 89 / 8871 (1.0%) | 4883 / 88710 (5.5%) | −105.8 | −103.3 | 0.18 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 135 / 8871 (1.5%) | 5765 / 88710 (6.5%) | −105.4 | −103.0 | 0.23 |
| ARID1A SRX5089376 | MCF-7 Breast | 129 / 8871 (1.5%) | 5652 / 88710 (6.4%) | −105.4 | −103.0 | 0.23 |
| ESR1 SRX20282954 | MCF-7 Breast | 175 / 8871 (2.0%) | 6472 / 88710 (7.3%) | −105.1 | −102.7 | 0.27 |
| ESR1 SRX4367192 | MCF-7 Breast | 347 / 8871 (3.9%) | 9242 / 88710 (10.4%) | −105.1 | −102.6 | 0.38 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 141 / 8871 (1.6%) | 46 / 88710 (0.1%) | −105.0 | −102.6 | 30.65 |
| RAC1 SRX10365541 | MCF-7 Breast | 68 / 8871 (0.8%) | 4420 / 88710 (5.0%) | −105.0 | −102.6 | 0.15 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 278 / 8871 (3.1%) | 8161 / 88710 (9.2%) | −104.7 | −102.3 | 0.34 |
| ESR1 SRX194572 | MCF-7 Breast | 90 / 8871 (1.0%) | 4867 / 88710 (5.5%) | −104.5 | −102.1 | 0.18 |
| FOXA1 SRX1161175 | MCF-7 Breast | 114 / 8871 (1.3%) | 5338 / 88710 (6.0%) | −104.4 | −102.0 | 0.21 |
| FOS SRX150478 | MCF 10A Breast | 426 / 8871 (4.8%) | 10377 / 88710 (11.7%) | −104.0 | −101.6 | 0.41 |
| BRPF3 SRX796084 | RKO Digestive tract | 823 / 8871 (9.3%) | 3345 / 88710 (3.8%) | −103.2 | −100.8 | 2.46 |
| ESR1 SRX20282972 | MCF-7 Breast | 180 / 8871 (2.0%) | 6498 / 88710 (7.3%) | −103.1 | −100.7 | 0.28 |
| TLE3 SRX4815191 | MCF-7 Breast | 158 / 8871 (1.8%) | 6113 / 88710 (6.9%) | −103.1 | −100.7 | 0.26 |
| FOXA1 SRX371480 | MCF-7 Breast | 99 / 8871 (1.1%) | 5002 / 88710 (5.6%) | −102.8 | −100.4 | 0.20 |
| FOXA1 SRX3923514 | MCF-7 Breast | 162 / 8871 (1.8%) | 6170 / 88710 (7.0%) | −102.7 | −100.3 | 0.26 |
| YAP1 SRX757326 | H2052 Lung | 366 / 8871 (4.1%) | 9435 / 88710 (10.6%) | −102.4 | −100.1 | 0.39 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 320 / 8871 (3.6%) | 604 / 88710 (0.7%) | −102.4 | −100.0 | 5.30 |
| FOXA1 SRX11222437 | MCF-7 Breast | 108 / 8871 (1.2%) | 5162 / 88710 (5.8%) | −102.3 | −100.0 | 0.21 |
| CEBPB SRX150632 | HeLa Uterus | 394 / 8871 (4.4%) | 9810 / 88710 (11.1%) | −101.3 | −99.0 | 0.40 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 149 / 8871 (1.7%) | 5883 / 88710 (6.6%) | −100.9 | −98.5 | 0.25 |
| FOXA1 SRX3931043 | MCF-7 Breast | 163 / 8871 (1.8%) | 6119 / 88710 (6.9%) | −100.4 | −98.1 | 0.27 |
| SSRP1 SRX3436567 | HT-1080 Bone | 239 / 8871 (2.7%) | 313 / 88710 (0.4%) | −100.2 | −97.9 | 7.64 |
| FOXA1 SRX11222441 | MCF-7 Breast | 119 / 8871 (1.3%) | 5314 / 88710 (6.0%) | −100.2 | −97.9 | 0.22 |
| ESR1 SRX20282955 | MCF-7 Breast | 176 / 8871 (2.0%) | 6335 / 88710 (7.1%) | −100.2 | −97.8 | 0.28 |
| BRPF3 SRX796085 | RKO Digestive tract | 593 / 8871 (6.7%) | 1998 / 88710 (2.3%) | −99.9 | −97.6 | 2.97 |
| AGO2 SRX6783958 | Hep G2 Liver | 656 / 8871 (7.4%) | 2370 / 88710 (2.7%) | −99.8 | −97.4 | 2.77 |
| ESR1 SRX371475 | BT-474 Breast | 68 / 8871 (0.8%) | 4274 / 88710 (4.8%) | −99.6 | −97.3 | 0.16 |
| GATA3 SRX176864 | MCF-7 Breast | 117 / 8871 (1.3%) | 5250 / 88710 (5.9%) | −99.5 | −97.1 | 0.22 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 106 / 8871 (1.2%) | 5038 / 88710 (5.7%) | −99.4 | −97.1 | 0.21 |
| ESR1 SRX20282973 | MCF-7 Breast | 203 / 8871 (2.3%) | 6756 / 88710 (7.6%) | −99.0 | −96.7 | 0.30 |
| ING5 SRX286202 | RKO Digestive tract | 725 / 8871 (8.2%) | 2802 / 88710 (3.2%) | −99.0 | −96.7 | 2.59 |
| ESR1 SRX10365536 | MCF-7 Breast | 75 / 8871 (0.8%) | 4406 / 88710 (5.0%) | −99.0 | −96.7 | 0.17 |
| BRPF3 SRX796086 | RKO Digestive tract | 781 / 8871 (8.8%) | 3160 / 88710 (3.6%) | −98.6 | −96.3 | 2.47 |
| RAC1 SRX10365543 | MCF-7 Breast | 75 / 8871 (0.8%) | 4389 / 88710 (4.9%) | −98.3 | −96.0 | 0.17 |
| ESR1 SRX20282940 | MCF-7 Breast | 185 / 8871 (2.1%) | 6420 / 88710 (7.2%) | −97.9 | −95.6 | 0.29 |
| ESR1 SRX2943591 | MCF-7 Breast | 107 / 8871 (1.2%) | 4996 / 88710 (5.6%) | −97.3 | −95.0 | 0.21 |
| FOXA1 SRX1961158 | T-47D Breast | 165 / 8871 (1.9%) | 6041 / 88710 (6.8%) | −96.9 | −94.6 | 0.27 |
| FOXA2 SRX100448 | Hep G2 Liver | 183 / 8871 (2.1%) | 6339 / 88710 (7.1%) | −96.5 | −94.2 | 0.29 |
| ESR1 SRX20282953 | MCF-7 Breast | 134 / 8871 (1.5%) | 5474 / 88710 (6.2%) | −96.4 | −94.0 | 0.24 |
| ESR1 SRX371477 | MCF-7 Breast | 69 / 8871 (0.8%) | 4203 / 88710 (4.7%) | −96.2 | −93.9 | 0.16 |
| ESR1 SRX20282946 | MCF-7 Breast | 93 / 8871 (1.0%) | 4673 / 88710 (5.3%) | −95.6 | −93.3 | 0.20 |
| ARID1A SRX5089379 | MCF-7 Breast | 165 / 8871 (1.9%) | 5979 / 88710 (6.7%) | −94.9 | −92.6 | 0.28 |
| AGO2 SRX6783957 | Hep G2 Liver | 656 / 8871 (7.4%) | 2448 / 88710 (2.8%) | −94.7 | −92.4 | 2.68 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 130 / 8871 (1.5%) | 5351 / 88710 (6.0%) | −94.6 | −92.3 | 0.24 |
| NR2F2 SRX190293 | MCF-7 Breast | 180 / 8871 (2.0%) | 6228 / 88710 (7.0%) | −94.6 | −92.3 | 0.29 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 292 / 8871 (3.3%) | 543 / 88710 (0.6%) | −94.6 | −92.3 | 5.38 |
| FOXA1 SRX100506 | Hep G2 Liver | 232 / 8871 (2.6%) | 7080 / 88710 (8.0%) | −94.4 | −92.1 | 0.33 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 157 / 8871 (1.8%) | 5821 / 88710 (6.6%) | −94.3 | −92.0 | 0.27 |
| ESR1 SRX20282971 | MCF-7 Breast | 169 / 8871 (1.9%) | 6026 / 88710 (6.8%) | −94.3 | −92.0 | 0.28 |
| FOXA1 SRX3931054 | MCF-7 Breast | 159 / 8871 (1.8%) | 5856 / 88710 (6.6%) | −94.2 | −91.9 | 0.27 |
| GATA3 SRX5057632 | MCF-7 Breast | 107 / 8871 (1.2%) | 4879 / 88710 (5.5%) | −93.2 | −91.0 | 0.22 |
| FOXA1 SRX1161203 | T-47D Breast | 116 / 8871 (1.3%) | 5044 / 88710 (5.7%) | −93.1 | −90.8 | 0.23 |
| FOXA1 SRX3931055 | MCF-7 Breast | 142 / 8871 (1.6%) | 5507 / 88710 (6.2%) | −92.7 | −90.4 | 0.26 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 192 / 8871 (2.2%) | 6367 / 88710 (7.2%) | −92.7 | −90.4 | 0.30 |
| ESR1 SRX10365535 | MCF-7 Breast | 139 / 8871 (1.6%) | 5448 / 88710 (6.1%) | −92.6 | −90.3 | 0.26 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 122 / 8871 (1.4%) | 5138 / 88710 (5.8%) | −92.5 | −90.2 | 0.24 |
| ESR1 SRX371474 | BT-474 Breast | 67 / 8871 (0.8%) | 4045 / 88710 (4.6%) | −92.2 | −89.9 | 0.17 |
| FOXA1 SRX1961157 | T-47D Breast | 190 / 8871 (2.1%) | 6307 / 88710 (7.1%) | −91.9 | −89.6 | 0.30 |
| EP300 SRX176885 | MCF-7 Breast | 81 / 8871 (0.9%) | 4312 / 88710 (4.9%) | −91.3 | −89.1 | 0.19 |
| ESR1 SRX2881002 | MCF-7 Breast | 164 / 8871 (1.8%) | 5848 / 88710 (6.6%) | −91.2 | −89.0 | 0.28 |
| JUNB SRX8488088 | SUM 229PE Breast | 355 / 8871 (4.0%) | 8859 / 88710 (10.0%) | −91.1 | −88.9 | 0.40 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 232 / 8871 (2.6%) | 6960 / 88710 (7.8%) | −90.8 | −88.5 | 0.33 |
| TLE3 SRX4815192 | MCF-7 Breast | 159 / 8871 (1.8%) | 5738 / 88710 (6.5%) | −90.6 | −88.3 | 0.28 |
| AR SRX9469988 | LAPC-4 Prostate | 239 / 8871 (2.7%) | 7060 / 88710 (8.0%) | −90.5 | −88.2 | 0.34 |
| EP300 SRX1012648 | MCF-7 Breast | 72 / 8871 (0.8%) | 4105 / 88710 (4.6%) | −90.4 | −88.2 | 0.18 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 733 / 8871 (8.3%) | 3001 / 88710 (3.4%) | −90.3 | −88.1 | 2.44 |
| FOXA2 SRX3230382 | Hep G2 Liver | 247 / 8871 (2.8%) | 7168 / 88710 (8.1%) | −89.9 | −87.6 | 0.34 |
| Epitope tags SRX10549778 | K-562 Blood | 607 / 8871 (6.8%) | 2231 / 88710 (2.5%) | −89.6 | −87.4 | 2.72 |
| ESR1 SRX2881000 | MCF-7 Breast | 155 / 8871 (1.7%) | 5626 / 88710 (6.3%) | −89.3 | −87.0 | 0.28 |
| ESR1 SRX330067 | MCF-7 Breast | 159 / 8871 (1.8%) | 5693 / 88710 (6.4%) | −89.1 | −86.9 | 0.28 |
| AR SRX9109110 | MDA-MB-453 Breast | 348 / 8871 (3.9%) | 8675 / 88710 (9.8%) | −89.0 | −86.8 | 0.40 |
| FOXA1 SRX5323829 | T-47D Breast | 89 / 8871 (1.0%) | 4403 / 88710 (5.0%) | −89.0 | −86.8 | 0.20 |
| PGR SRX1012655 | MCF-7 Breast | 105 / 8871 (1.2%) | 4714 / 88710 (5.3%) | −89.0 | −86.7 | 0.22 |
| FOXA1 SRX15430999 | T-47D Breast | 200 / 8871 (2.3%) | 6377 / 88710 (7.2%) | −88.9 | −86.7 | 0.31 |
| FOXA1 SRX5323830 | T-47D Breast | 95 / 8871 (1.1%) | 4512 / 88710 (5.1%) | −88.7 | −86.5 | 0.21 |
| CIC SRX13262055 | Astrocytes Neural | 1562 / 8871 (17.6%) | 9037 / 88710 (10.2%) | −88.5 | −86.3 | 1.73 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 558 / 8871 (6.3%) | 11617 / 88710 (13.1%) | −88.5 | −86.3 | 0.48 |
| TEAD1 SRX3401272 | MCF-7 Breast | 130 / 8871 (1.5%) | 5162 / 88710 (5.8%) | −88.5 | −86.3 | 0.25 |
| FOXA1 SRX1787652 | MCF-7 Breast | 99 / 8871 (1.1%) | 4580 / 88710 (5.2%) | −88.3 | −86.1 | 0.22 |
| ARID1A SRX5089385 | MCF-7 Breast | 129 / 8871 (1.5%) | 5134 / 88710 (5.8%) | −88.3 | −86.1 | 0.25 |
| FOXA1 SRX1447317 | MCF-7 Breast | 111 / 8871 (1.3%) | 4802 / 88710 (5.4%) | −88.2 | −86.0 | 0.23 |
| ESR1 SRX10365532 | MCF-7 Breast | 90 / 8871 (1.0%) | 4399 / 88710 (5.0%) | −88.1 | −85.9 | 0.20 |
| FOXA1 SRX3923517 | MCF-7 Breast | 123 / 8871 (1.4%) | 5012 / 88710 (5.6%) | −87.7 | −85.5 | 0.25 |
| FOXA1 SRX1787651 | MCF-7 Breast | 93 / 8871 (1.0%) | 4442 / 88710 (5.0%) | −87.6 | −85.4 | 0.21 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 241 / 8871 (2.7%) | 6992 / 88710 (7.9%) | −87.6 | −85.4 | 0.34 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 247 / 8871 (2.8%) | 7077 / 88710 (8.0%) | −87.3 | −85.1 | 0.35 |
| FOXA1 SRX11222442 | MCF-7 Breast | 118 / 8871 (1.3%) | 4901 / 88710 (5.5%) | −87.2 | −85.0 | 0.24 |
| LEO1 SRX1873456 | SEM Blood | 772 / 8871 (8.7%) | 3317 / 88710 (3.7%) | −86.9 | −84.7 | 2.33 |
| FOXA1 SRX3923518 | MCF-7 Breast | 118 / 8871 (1.3%) | 4891 / 88710 (5.5%) | −86.9 | −84.7 | 0.24 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 499 / 8871 (5.6%) | 10739 / 88710 (12.1%) | −86.8 | −84.6 | 0.46 |
| EP300 SRX1012644 | MCF-7 Breast | 70 / 8871 (0.8%) | 3957 / 88710 (4.5%) | −86.8 | −84.6 | 0.18 |
| ESR1 SRX10365533 | MCF-7 Breast | 74 / 8871 (0.8%) | 4033 / 88710 (4.5%) | −86.5 | −84.4 | 0.18 |
| FOXA1 SRX3923516 | MCF-7 Breast | 126 / 8871 (1.4%) | 5026 / 88710 (5.7%) | −86.5 | −84.3 | 0.25 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 111 / 8871 (1.3%) | 30 / 88710 (0.0%) | −86.5 | −84.3 | 37.00 |
| ARID1A SRX5089391 | MCF-7 Breast | 96 / 8871 (1.1%) | 4459 / 88710 (5.0%) | −86.3 | −84.1 | 0.22 |
| FOS SRX4192880 | MCF 10A Breast | 327 / 8871 (3.7%) | 8261 / 88710 (9.3%) | −86.3 | −84.1 | 0.40 |
| FOXA1 SRX5323843 | MCF-7 Breast | 85 / 8871 (1.0%) | 4244 / 88710 (4.8%) | −86.2 | −84.0 | 0.20 |
| SSRP1 SRX3436566 | HT-1080 Bone | 178 / 8871 (2.0%) | 185 / 88710 (0.2%) | −85.7 | −83.5 | 9.62 |
| ZEB1 SRX13298925 | MCF-7 Breast | 109 / 8871 (1.2%) | 4686 / 88710 (5.3%) | −85.6 | −83.4 | 0.23 |
| ESR1 SRX20282938 | MCF-7 Breast | 146 / 8871 (1.6%) | 5349 / 88710 (6.0%) | −85.4 | −83.3 | 0.27 |
| ESR1 SRX2943589 | MCF-7 Breast | 86 / 8871 (1.0%) | 4240 / 88710 (4.8%) | −85.4 | −83.3 | 0.20 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 471 / 8871 (5.3%) | 1505 / 88710 (1.7%) | −85.4 | −83.2 | 3.13 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 174 / 8871 (2.0%) | 5826 / 88710 (6.6%) | −85.3 | −83.1 | 0.30 |
| CDK9 SRX7366779 | MCF-7 Breast | 130 / 8871 (1.5%) | 66 / 88710 (0.1%) | −85.3 | −83.1 | 19.70 |
| FOXA1 SRX028634 | MCF-7 Breast | 83 / 8871 (0.9%) | 4171 / 88710 (4.7%) | −85.0 | −82.8 | 0.20 |
| FOXA1 SRX9604647 | LNCAP Prostate | 297 / 8871 (3.3%) | 7755 / 88710 (8.7%) | −84.7 | −82.6 | 0.38 |
| FOXA1 SRX11222438 | MCF-7 Breast | 92 / 8871 (1.0%) | 4324 / 88710 (4.9%) | −84.2 | −82.0 | 0.21 |
| ESR1 SRX330070 | MCF-7 Breast | 88 / 8871 (1.0%) | 4245 / 88710 (4.8%) | −84.1 | −81.9 | 0.21 |
| ARID5B SRX3230377 | Hep G2 Liver | 479 / 8871 (5.4%) | 10354 / 88710 (11.7%) | −84.0 | −81.9 | 0.46 |
| GATA3 SRX6712581 | MCF-7 Breast | 152 / 8871 (1.7%) | 5408 / 88710 (6.1%) | −84.0 | −81.9 | 0.28 |
| ESR1 SRX5323871 | MCF-7 Breast | 205 / 8871 (2.3%) | 6289 / 88710 (7.1%) | −83.8 | −81.7 | 0.33 |
| FOXA1 SRX3923519 | MCF-7 Breast | 109 / 8871 (1.2%) | 4626 / 88710 (5.2%) | −83.6 | −81.5 | 0.24 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 158 / 8871 (1.8%) | 5497 / 88710 (6.2%) | −83.5 | −81.3 | 0.29 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 175 / 8871 (2.0%) | 5781 / 88710 (6.5%) | −83.4 | −81.3 | 0.30 |
| ESR1 SRX3110725 | MCF-7 Breast | 168 / 8871 (1.9%) | 5660 / 88710 (6.4%) | −83.3 | −81.2 | 0.30 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 84 / 8871 (0.9%) | 4141 / 88710 (4.7%) | −83.3 | −81.2 | 0.20 |
| ARID1A SRX5089382 | MCF-7 Breast | 128 / 8871 (1.4%) | 4962 / 88710 (5.6%) | −83.3 | −81.1 | 0.26 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 86 / 8871 (1.0%) | 4179 / 88710 (4.7%) | −83.2 | −81.1 | 0.21 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 119 / 8871 (1.3%) | 4801 / 88710 (5.4%) | −83.2 | −81.1 | 0.25 |
| ESR1 SRX4451213 | MCF-7 Breast | 191 / 8871 (2.2%) | 6039 / 88710 (6.8%) | −83.2 | −81.1 | 0.32 |
| ESR1 SRX5323872 | MCF-7 Breast | 188 / 8871 (2.1%) | 5982 / 88710 (6.7%) | −83.0 | −80.8 | 0.31 |
| FOXA1 SRX6878603 | LNCAP Prostate | 213 / 8871 (2.4%) | 6381 / 88710 (7.2%) | −82.8 | −80.6 | 0.33 |
| ESR1 SRX5323873 | MCF-7 Breast | 237 / 8871 (2.7%) | 6760 / 88710 (7.6%) | −82.7 | −80.5 | 0.35 |
| ESR1 SRX20282959 | MCF-7 Breast | 70 / 8871 (0.8%) | 3840 / 88710 (4.3%) | −82.7 | −80.5 | 0.18 |
| STAT3 SRX2020842 | HCC70 Breast | 342 / 8871 (3.9%) | 8347 / 88710 (9.4%) | −82.6 | −80.5 | 0.41 |
| ESR1 SRX330069 | MCF-7 Breast | 107 / 8871 (1.2%) | 4558 / 88710 (5.1%) | −82.6 | −80.5 | 0.23 |
| AR SRX9109113 | MDA-MB-453 Breast | 370 / 8871 (4.2%) | 8743 / 88710 (9.9%) | −82.3 | −80.2 | 0.42 |
| ESR1 SRX8537722 | MCF-7 Breast | 181 / 8871 (2.0%) | 5843 / 88710 (6.6%) | −82.3 | −80.2 | 0.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 122 / 8871 (1.4%) | 4820 / 88710 (5.4%) | −82.1 | −80.0 | 0.25 |
| ESR1 SRX3123829 | MCF-7 Breast | 104 / 8871 (1.2%) | 4478 / 88710 (5.0%) | −81.8 | −79.6 | 0.23 |
| ARID1A SRX5089388 | MCF-7 Breast | 88 / 8871 (1.0%) | 4170 / 88710 (4.7%) | −81.7 | −79.5 | 0.21 |
| FOXA1 SRX1787655 | MCF-7 Breast | 85 / 8871 (1.0%) | 4114 / 88710 (4.6%) | −81.6 | −79.5 | 0.21 |
| FOXA1 SRX028635 | MCF-7 Breast | 89 / 8871 (1.0%) | 4185 / 88710 (4.7%) | −81.6 | −79.5 | 0.21 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 286 / 8871 (3.2%) | 7476 / 88710 (8.4%) | −81.5 | −79.4 | 0.38 |
| ESR1 SRX1469949 | MCF-7 Breast | 103 / 8871 (1.2%) | 4452 / 88710 (5.0%) | −81.5 | −79.4 | 0.23 |
| VGLL1 SRX24602130 | BT-20 Breast | 196 / 8871 (2.2%) | 6063 / 88710 (6.8%) | −81.4 | −79.3 | 0.32 |
| NCOA1 SRX036638 | U2OS Bone | 108 / 8871 (1.2%) | 34 / 88710 (0.0%) | −81.3 | −79.2 | 31.76 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 121 / 8871 (1.4%) | 4770 / 88710 (5.4%) | −81.2 | −79.1 | 0.25 |
| ESR1 SRX1531796 | MCF-7 Breast | 96 / 8871 (1.1%) | 4308 / 88710 (4.9%) | −81.0 | −78.9 | 0.22 |
| FOXA1 SRX219284 | LNCAP Prostate | 269 / 8871 (3.0%) | 7192 / 88710 (8.1%) | −81.0 | −78.9 | 0.37 |
| IRF3 SRX11453864 | Hep G2 Liver | 101 / 8871 (1.1%) | 24 / 88710 (0.0%) | −80.9 | −78.8 | 42.08 |
| FOXA1 SRX3923515 | MCF-7 Breast | 101 / 8871 (1.1%) | 4390 / 88710 (4.9%) | −80.8 | −78.7 | 0.23 |
| FOXA1 SRX3931033 | MCF-7 Breast | 116 / 8871 (1.3%) | 4669 / 88710 (5.3%) | −80.7 | −78.6 | 0.25 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 164 / 8871 (1.8%) | 5506 / 88710 (6.2%) | −80.7 | −78.6 | 0.30 |
| FOS SRX150517 | MCF 10A Breast | 337 / 8871 (3.8%) | 8199 / 88710 (9.2%) | −80.6 | −78.5 | 0.41 |
| ESR1 SRX10365558 | MCF-7 Breast | 126 / 8871 (1.4%) | 4845 / 88710 (5.5%) | −80.6 | −78.5 | 0.26 |
| ESR1 SRX1012629 | MCF-7 Breast | 117 / 8871 (1.3%) | 4680 / 88710 (5.3%) | −80.5 | −78.4 | 0.25 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 103 / 8871 (1.2%) | 4422 / 88710 (5.0%) | −80.5 | −78.4 | 0.23 |
| ESR1 SRX5323878 | MCF-7 Breast | 194 / 8871 (2.2%) | 5989 / 88710 (6.8%) | −80.2 | −78.1 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 423 / 8871 (4.8%) | 1311 / 88710 (1.5%) | −79.8 | −77.7 | 3.23 |
| FOXA1 SRX1961163 | T-47D Breast | 123 / 8871 (1.4%) | 4759 / 88710 (5.4%) | −79.6 | −77.5 | 0.26 |
| AR SRX1067071 | LHSAR Prostate | 388 / 8871 (4.4%) | 8894 / 88710 (10.0%) | −79.5 | −77.4 | 0.44 |
| EP300 SRX1012643 | MCF-7 Breast | 60 / 8871 (0.7%) | 3543 / 88710 (4.0%) | −79.5 | −77.4 | 0.17 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 888 / 8871 (10.0%) | 4263 / 88710 (4.8%) | −79.5 | −77.4 | 2.08 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 339 / 8871 (3.8%) | 8182 / 88710 (9.2%) | −79.4 | −77.3 | 0.41 |
| FOXA1 SRX5203303 | MCF-7 Breast | 56 / 8871 (0.6%) | 3452 / 88710 (3.9%) | −79.3 | −77.2 | 0.16 |
| CEBPA SRX2630241 | Hep G2 Liver | 240 / 8871 (2.7%) | 6682 / 88710 (7.5%) | −79.2 | −77.1 | 0.36 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 173 / 8871 (2.0%) | 5603 / 88710 (6.3%) | −79.1 | −77.0 | 0.31 |
| ESR1 SRX4451212 | MCF-7 Breast | 184 / 8871 (2.1%) | 5776 / 88710 (6.5%) | −78.9 | −76.8 | 0.32 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 157 / 8871 (1.8%) | 5326 / 88710 (6.0%) | −78.8 | −76.7 | 0.29 |
| TP53 SRX396254 | Fibroblasts Others | 455 / 8871 (5.1%) | 1500 / 88710 (1.7%) | −78.8 | −76.7 | 3.03 |
| FOXA1 SRX1161205 | T-47D Breast | 99 / 8871 (1.1%) | 4293 / 88710 (4.8%) | −78.7 | −76.6 | 0.23 |
| TRP47 SRX4548329 | THP-1 Blood | 1322 / 8871 (14.9%) | 7486 / 88710 (8.4%) | −78.6 | −76.5 | 1.77 |
| VGLL1 SRX18013277 | FULVR Breast | 75 / 8871 (0.8%) | 3819 / 88710 (4.3%) | −78.4 | −76.4 | 0.20 |
| FOXA1 SRX3931032 | MCF-7 Breast | 109 / 8871 (1.2%) | 4464 / 88710 (5.0%) | −78.2 | −76.2 | 0.24 |
| RELA SRX2207673 | HUVEC Cardiovascular | 711 / 8871 (8.0%) | 13187 / 88710 (14.9%) | −78.2 | −76.2 | 0.54 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 395 / 8871 (4.5%) | 1181 / 88710 (1.3%) | −78.1 | −76.0 | 3.34 |
| ESR1 SRX1012633 | MCF-7 Breast | 97 / 8871 (1.1%) | 4231 / 88710 (4.8%) | −77.9 | −75.9 | 0.23 |
| CEBPB SRX190345 | MCF-7 Breast | 148 / 8871 (1.7%) | 5139 / 88710 (5.8%) | −77.8 | −75.8 | 0.29 |
| ESR1 SRX330068 | MCF-7 Breast | 86 / 8871 (1.0%) | 4014 / 88710 (4.5%) | −77.7 | −75.7 | 0.21 |
| FOXA1 SRX15431000 | T-47D Breast | 159 / 8871 (1.8%) | 5321 / 88710 (6.0%) | −77.6 | −75.6 | 0.30 |
| AR SRX1067070 | LHSAR Prostate | 484 / 8871 (5.5%) | 10156 / 88710 (11.4%) | −77.6 | −75.5 | 0.48 |
| FOXA1 SRX100477 | Hep G2 Liver | 224 / 8871 (2.5%) | 6370 / 88710 (7.2%) | −77.4 | −75.4 | 0.35 |
| AR SRX1067066 | LHSAR Prostate | 425 / 8871 (4.8%) | 9326 / 88710 (10.5%) | −77.3 | −75.2 | 0.46 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 194 / 8871 (2.2%) | 5886 / 88710 (6.6%) | −77.2 | −75.1 | 0.33 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 210 / 8871 (2.4%) | 6131 / 88710 (6.9%) | −76.9 | −74.9 | 0.34 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 392 / 8871 (4.4%) | 8843 / 88710 (10.0%) | −76.8 | −74.8 | 0.44 |
| STAT3 SRX5323860 | MCF-7 Breast | 253 / 8871 (2.9%) | 6795 / 88710 (7.7%) | −76.7 | −74.7 | 0.37 |
| SOX13 SRX2636248 | Hep G2 Liver | 277 / 8871 (3.1%) | 7155 / 88710 (8.1%) | −76.6 | −74.6 | 0.39 |
| TFAP2C SRX018833 | MCF-7 Breast | 184 / 8871 (2.1%) | 5698 / 88710 (6.4%) | −76.5 | −74.5 | 0.32 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 219 / 8871 (2.5%) | 6260 / 88710 (7.1%) | −76.5 | −74.4 | 0.35 |
| FOXA1 SRX15391842 | T-47D Breast | 108 / 8871 (1.2%) | 4385 / 88710 (4.9%) | −76.4 | −74.3 | 0.25 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 166 / 8871 (1.9%) | 5393 / 88710 (6.1%) | −76.3 | −74.3 | 0.31 |
| TFAP2C SRX128099 | MCF-7 Breast | 185 / 8871 (2.1%) | 5702 / 88710 (6.4%) | −76.2 | −74.2 | 0.32 |
| FOXA1 SRX9604646 | LNCAP Prostate | 284 / 8871 (3.2%) | 7241 / 88710 (8.2%) | −76.1 | −74.0 | 0.39 |
| KMT2C SRX1787675 | MCF-7 Breast | 176 / 8871 (2.0%) | 5546 / 88710 (6.3%) | −76.0 | −73.9 | 0.32 |
| FOXA1 SRX1161207 | T-47D Breast | 75 / 8871 (0.8%) | 3745 / 88710 (4.2%) | −75.8 | −73.7 | 0.20 |
| ESR1 SRX1012632 | MCF-7 Breast | 96 / 8871 (1.1%) | 4146 / 88710 (4.7%) | −75.8 | −73.7 | 0.23 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 193 / 8871 (2.2%) | 5814 / 88710 (6.6%) | −75.6 | −73.5 | 0.33 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 716 / 8871 (8.1%) | 13115 / 88710 (14.8%) | −75.2 | −73.2 | 0.55 |
| KAT7 DRX234808 | 293 Kidney | 397 / 8871 (4.5%) | 1227 / 88710 (1.4%) | −75.2 | −73.1 | 3.24 |
| ESR1 SRX5534831 | MCF-7 Breast | 154 / 8871 (1.7%) | 5154 / 88710 (5.8%) | −75.1 | −73.1 | 0.30 |
| ESR1 SRX1469951 | MCF-7 Breast | 100 / 8871 (1.1%) | 4197 / 88710 (4.7%) | −75.0 | −73.0 | 0.24 |
| GATA3 SRX100559 | T-47D Breast | 223 / 8871 (2.5%) | 6263 / 88710 (7.1%) | −74.9 | −72.9 | 0.36 |
| SREBF2 SRX5359048 | HCC70 Breast | 860 / 8871 (9.7%) | 4174 / 88710 (4.7%) | −74.8 | −72.8 | 2.06 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 207 / 8871 (2.3%) | 6008 / 88710 (6.8%) | −74.8 | −72.8 | 0.34 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 195 / 8871 (2.2%) | 5814 / 88710 (6.6%) | −74.7 | −72.7 | 0.34 |
| MethylCap SRX014767 | NB-4 Blood | 886 / 8871 (10.0%) | 4362 / 88710 (4.9%) | −74.7 | −72.7 | 2.03 |
| FOXA1 SRX6860635 | T-47D Breast | 150 / 8871 (1.7%) | 5069 / 88710 (5.7%) | −74.6 | −72.6 | 0.30 |
| FOXA1 SRX1447316 | MCF-7 Breast | 81 / 8871 (0.9%) | 3822 / 88710 (4.3%) | −74.5 | −72.5 | 0.21 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 204 / 8871 (2.3%) | 5950 / 88710 (6.7%) | −74.5 | −72.5 | 0.34 |
| ESR1 SRX371446 | Tumour tissues Others | 213 / 8871 (2.4%) | 6087 / 88710 (6.9%) | −74.4 | −72.3 | 0.35 |
| ESR1 SRX792933 | LY2 Breast | 164 / 8871 (1.8%) | 5293 / 88710 (6.0%) | −74.3 | −72.2 | 0.31 |
| GATAD2A SRX2636506 | Hep G2 Liver | 261 / 8871 (2.9%) | 6825 / 88710 (7.7%) | −74.2 | −72.2 | 0.38 |
| FOXA1 SRX9604645 | LNCAP Prostate | 296 / 8871 (3.3%) | 7348 / 88710 (8.3%) | −74.1 | −72.1 | 0.40 |
| FOXA1 SRX3931056 | MCF-7 Breast | 117 / 8871 (1.3%) | 4475 / 88710 (5.0%) | −74.1 | −72.0 | 0.26 |
| PGR SRX3990986 | T-47D Breast | 175 / 8871 (2.0%) | 5465 / 88710 (6.2%) | −74.0 | −72.0 | 0.32 |
| FOXA1 SRX2017928 | LNCAP Prostate | 242 / 8871 (2.7%) | 6528 / 88710 (7.4%) | −74.0 | −72.0 | 0.37 |
| ESR1 SRX8537723 | MCF-7 Breast | 168 / 8871 (1.9%) | 5351 / 88710 (6.0%) | −74.0 | −72.0 | 0.31 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 500 / 8871 (5.6%) | 10216 / 88710 (11.5%) | −73.9 | −71.9 | 0.49 |
| RELA SRX2207672 | HUVEC Cardiovascular | 776 / 8871 (8.7%) | 13814 / 88710 (15.6%) | −73.8 | −71.8 | 0.56 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 375 / 8871 (4.2%) | 1125 / 88710 (1.3%) | −73.8 | −71.8 | 3.33 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 193 / 8871 (2.2%) | 5737 / 88710 (6.5%) | −73.4 | −71.4 | 0.34 |
| MethylCap SRX014766 | NB-4 Blood | 810 / 8871 (9.1%) | 3860 / 88710 (4.4%) | −73.3 | −71.3 | 2.10 |
| FOXA1 SRX5323828 | T-47D Breast | 77 / 8871 (0.9%) | 3710 / 88710 (4.2%) | −73.3 | −71.3 | 0.21 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 195 / 8871 (2.2%) | 5757 / 88710 (6.5%) | −73.1 | −71.1 | 0.34 |
| ESR1 SRX10365534 | MCF-7 Breast | 54 / 8871 (0.6%) | 3229 / 88710 (3.6%) | −72.9 | −70.9 | 0.17 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 341 / 8871 (3.8%) | 957 / 88710 (1.1%) | −72.9 | −70.9 | 3.56 |
| FOXA1 SRX5323846 | MCF-7 Breast | 72 / 8871 (0.8%) | 3598 / 88710 (4.1%) | −72.9 | −70.9 | 0.20 |
| CDK9 SRX7366780 | MCF-7 Breast | 114 / 8871 (1.3%) | 63 / 88710 (0.1%) | −72.7 | −70.7 | 18.10 |
| FOXA1 SRX10306473 | T-47D Breast | 80 / 8871 (0.9%) | 3746 / 88710 (4.2%) | −72.5 | −70.5 | 0.21 |
| ESR1 SRX2912055 | MCF-7 Breast | 76 / 8871 (0.9%) | 3666 / 88710 (4.1%) | −72.4 | −70.5 | 0.21 |
| MITF SRX1555436 | 501A Epidermis | 985 / 8871 (11.1%) | 5132 / 88710 (5.8%) | −72.3 | −70.4 | 1.92 |
| FOXA1 SRX5323845 | MCF-7 Breast | 70 / 8871 (0.8%) | 3543 / 88710 (4.0%) | −72.3 | −70.4 | 0.20 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 61 / 8871 (0.7%) | 3359 / 88710 (3.8%) | −72.2 | −70.2 | 0.18 |
| FOXA1 SRX3923511 | MCF-7 Breast | 74 / 8871 (0.8%) | 3618 / 88710 (4.1%) | −72.2 | −70.2 | 0.20 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 194 / 8871 (2.2%) | 5709 / 88710 (6.4%) | −72.2 | −70.2 | 0.34 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 251 / 8871 (2.8%) | 6599 / 88710 (7.4%) | −72.2 | −70.2 | 0.38 |
| HMG20A SRX2630163 | Hep G2 Liver | 114 / 8871 (1.3%) | 4360 / 88710 (4.9%) | −72.0 | −70.1 | 0.26 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 124 / 8871 (1.4%) | 4536 / 88710 (5.1%) | −71.9 | −70.0 | 0.27 |
| ZEB1 SRX13298923 | MCF-7 Breast | 86 / 8871 (1.0%) | 3844 / 88710 (4.3%) | −71.9 | −70.0 | 0.22 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 970 / 8871 (10.9%) | 5036 / 88710 (5.7%) | −71.9 | −69.9 | 1.93 |
| FOXA1 SRX190181 | A549 Lung | 150 / 8871 (1.7%) | 4977 / 88710 (5.6%) | −71.8 | −69.9 | 0.30 |
| ESR1 SRX2513518 | MCF-7 Breast | 99 / 8871 (1.1%) | 4082 / 88710 (4.6%) | −71.8 | −69.8 | 0.24 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 170 / 8871 (1.9%) | 5310 / 88710 (6.0%) | −71.8 | −69.8 | 0.32 |
| ESR1 SRX2513517 | MCF-7 Breast | 143 / 8871 (1.6%) | 4854 / 88710 (5.5%) | −71.8 | −69.8 | 0.29 |
| GATA3 SRX5457550 | MCF-7 Breast | 233 / 8871 (2.6%) | 6309 / 88710 (7.1%) | −71.7 | −69.8 | 0.37 |
| FOXL2 SRX6957431 | KGN Gonad | 479 / 8871 (5.4%) | 9835 / 88710 (11.1%) | −71.7 | −69.7 | 0.49 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 72 / 8871 (0.8%) | 3563 / 88710 (4.0%) | −71.7 | −69.7 | 0.20 |
| KDM6A SRX15826236 | MCF-7 Breast | 61 / 8871 (0.7%) | 3341 / 88710 (3.8%) | −71.6 | −69.6 | 0.18 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 678 / 8871 (7.6%) | 12455 / 88710 (14.0%) | −71.6 | −69.6 | 0.54 |
| FOXA1 SRX5203307 | MCF-7 Breast | 57 / 8871 (0.6%) | 3250 / 88710 (3.7%) | −71.4 | −69.4 | 0.18 |
| FOXA1 SRX5203294 | MCF-7 Breast | 54 / 8871 (0.6%) | 3185 / 88710 (3.6%) | −71.3 | −69.4 | 0.17 |
| MEAF6 DRX234811 | 293 Kidney | 834 / 8871 (9.4%) | 4078 / 88710 (4.6%) | −71.2 | −69.2 | 2.05 |
| FOXA1 SRX1787654 | MCF-7 Breast | 72 / 8871 (0.8%) | 3545 / 88710 (4.0%) | −71.0 | −69.1 | 0.20 |
| RBFOX2 SRX4708082 | K-562 Blood | 1186 / 8871 (13.4%) | 6679 / 88710 (7.5%) | −71.0 | −69.1 | 1.78 |
| ZEB1 SRX13298924 | MCF-7 Breast | 100 / 8871 (1.1%) | 4074 / 88710 (4.6%) | −71.0 | −69.0 | 0.25 |
| GATAD2A SRX2636507 | Hep G2 Liver | 228 / 8871 (2.6%) | 6202 / 88710 (7.0%) | −70.9 | −69.0 | 0.37 |
| FOXA1 SRX497612 | VCaP Prostate | 205 / 8871 (2.3%) | 5839 / 88710 (6.6%) | −70.9 | −69.0 | 0.35 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 488 / 8871 (5.5%) | 9920 / 88710 (11.2%) | −70.8 | −68.9 | 0.49 |
| NR3C1 SRX8520802 | HCC1187 Breast | 157 / 8871 (1.8%) | 5061 / 88710 (5.7%) | −70.8 | −68.9 | 0.31 |
| ARID5B SRX10475138 | Hep G2 Liver | 352 / 8871 (4.0%) | 8032 / 88710 (9.1%) | −70.7 | −68.8 | 0.44 |
| FOXA1 SRX2642368 | VCaP Prostate | 263 / 8871 (3.0%) | 6726 / 88710 (7.6%) | −70.6 | −68.7 | 0.39 |
| MEAF6 DRX300417 | 293 Kidney | 765 / 8871 (8.6%) | 3610 / 88710 (4.1%) | −70.6 | −68.6 | 2.12 |
| ESR1 SRX2513520 | MCF-7 Breast | 131 / 8871 (1.5%) | 4611 / 88710 (5.2%) | −70.5 | −68.5 | 0.28 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 138 / 8871 (1.6%) | 4722 / 88710 (5.3%) | −70.2 | −68.3 | 0.29 |
| FOXA1 SRX6878604 | LNCAP Prostate | 175 / 8871 (2.0%) | 5335 / 88710 (6.0%) | −70.2 | −68.3 | 0.33 |
| ESR1 SRX1012628 | MCF-7 Breast | 108 / 8871 (1.2%) | 4195 / 88710 (4.7%) | −70.2 | −68.2 | 0.26 |
| FOS SRX150476 | MCF 10A Breast | 372 / 8871 (4.2%) | 8290 / 88710 (9.3%) | −70.1 | −68.2 | 0.45 |
| ESR1 SRX3110723 | MCF-7 Breast | 117 / 8871 (1.3%) | 4355 / 88710 (4.9%) | −70.1 | −68.2 | 0.27 |
| EP300 SRX176883 | MCF-7 Breast | 96 / 8871 (1.1%) | 3974 / 88710 (4.5%) | −70.1 | −68.2 | 0.24 |
| Epitope tags DRX443510 | 293 Kidney | 718 / 8871 (8.1%) | 3303 / 88710 (3.7%) | −70.0 | −68.1 | 2.17 |
| CDK9 SRX7366782 | MCF-7 Breast | 106 / 8871 (1.2%) | 53 / 88710 (0.1%) | −70.0 | −68.1 | 20.00 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 251 / 8871 (2.8%) | 552 / 88710 (0.6%) | −69.9 | −68.0 | 4.55 |
| FOXA1 SRX6860646 | T-47D Breast | 117 / 8871 (1.3%) | 4342 / 88710 (4.9%) | −69.8 | −67.9 | 0.27 |
| NCOA3 SRX4663589 | MCF-7 Breast | 53 / 8871 (0.6%) | 3120 / 88710 (3.5%) | −69.8 | −67.8 | 0.17 |
| ESR1 SRX2513521 | MCF-7 Breast | 99 / 8871 (1.1%) | 4016 / 88710 (4.5%) | −69.7 | −67.8 | 0.25 |
| FOXA1 SRX2017929 | LNCAP Prostate | 282 / 8871 (3.2%) | 6974 / 88710 (7.9%) | −69.7 | −67.8 | 0.40 |
| ESR1 SRX3123823 | MCF-7 Breast | 71 / 8871 (0.8%) | 3481 / 88710 (3.9%) | −69.6 | −67.7 | 0.20 |
| FOXA1 SRX3931073 | MCF-7 Breast | 127 / 8871 (1.4%) | 4509 / 88710 (5.1%) | −69.5 | −67.6 | 0.28 |
| VGLL1 SRX18013279 | FULVR Breast | 99 / 8871 (1.1%) | 4008 / 88710 (4.5%) | −69.4 | −67.5 | 0.25 |
| ESR1 SRX1012625 | MCF-7 Breast | 112 / 8871 (1.3%) | 4241 / 88710 (4.8%) | −69.4 | −67.4 | 0.26 |
| ESR1 SRX5323877 | MCF-7 Breast | 169 / 8871 (1.9%) | 5208 / 88710 (5.9%) | −69.3 | −67.4 | 0.32 |
| MAU2 SRX11120893 | MCF-7 Breast | 82 / 8871 (0.9%) | 3684 / 88710 (4.2%) | −69.3 | −67.4 | 0.22 |
| Epitope tags SRX5877912 | U2OS Bone | 1160 / 8871 (13.1%) | 18268 / 88710 (20.6%) | −69.2 | −67.3 | 0.63 |
| NR3C1 SRX19024866 | MCF-7 Breast | 72 / 8871 (0.8%) | 3489 / 88710 (3.9%) | −69.2 | −67.3 | 0.21 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 415 / 8871 (4.7%) | 8853 / 88710 (10.0%) | −69.2 | −67.3 | 0.47 |
| BMI1 SRX7196721 | SF8628 Neural | 862 / 8871 (9.7%) | 4326 / 88710 (4.9%) | −69.2 | −67.3 | 1.99 |
| PROX1 SRX3230397 | Hep G2 Liver | 153 / 8871 (1.7%) | 4934 / 88710 (5.6%) | −69.1 | −67.2 | 0.31 |
| FOXA1 SRX3931031 | MCF-7 Breast | 98 / 8871 (1.1%) | 3979 / 88710 (4.5%) | −69.1 | −67.1 | 0.25 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 87 / 8871 (1.0%) | 3774 / 88710 (4.3%) | −69.0 | −67.1 | 0.23 |
| ESR1 SRX11120903 | MCF-7 Breast | 188 / 8871 (2.1%) | 5501 / 88710 (6.2%) | −69.0 | −67.1 | 0.34 |
| Epitope tags SRX10549777 | K-562 Blood | 1214 / 8871 (13.7%) | 6965 / 88710 (7.9%) | −68.8 | −66.9 | 1.74 |
| GATA3 SRX190194 | SK-N-SH Neural | 495 / 8871 (5.6%) | 9926 / 88710 (11.2%) | −68.8 | −66.9 | 0.50 |
| TEAD3 SRX2636153 | Hep G2 Liver | 504 / 8871 (5.7%) | 10038 / 88710 (11.3%) | −68.6 | −66.7 | 0.50 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 148 / 8871 (1.7%) | 4834 / 88710 (5.4%) | −68.5 | −66.6 | 0.31 |
| FOXA1 SRX497613 | VCaP Prostate | 156 / 8871 (1.8%) | 4964 / 88710 (5.6%) | −68.5 | −66.6 | 0.31 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 147 / 8871 (1.7%) | 4812 / 88710 (5.4%) | −68.4 | −66.5 | 0.31 |
| RUNX1 SRX2014504 | Jurkat Blood | 1202 / 8871 (13.5%) | 6884 / 88710 (7.8%) | −68.4 | −66.5 | 1.75 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 681 / 8871 (7.7%) | 12343 / 88710 (13.9%) | −68.3 | −66.4 | 0.55 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 133 / 8871 (1.5%) | 4571 / 88710 (5.2%) | −68.3 | −66.4 | 0.29 |
| FOXA1 SRX2642367 | VCaP Prostate | 190 / 8871 (2.1%) | 5511 / 88710 (6.2%) | −68.3 | −66.4 | 0.34 |
| ARID5B SRX10475139 | Hep G2 Liver | 232 / 8871 (2.6%) | 6165 / 88710 (6.9%) | −68.2 | −66.3 | 0.38 |
| FOXA2 SRX10475773 | Hep G2 Liver | 262 / 8871 (3.0%) | 6618 / 88710 (7.5%) | −68.2 | −66.3 | 0.40 |
| FOXA1 SRX2642365 | VCaP Prostate | 206 / 8871 (2.3%) | 5755 / 88710 (6.5%) | −68.1 | −66.2 | 0.36 |
| EP300 SRX150579 | HeLa Uterus | 144 / 8871 (1.6%) | 4751 / 88710 (5.4%) | −68.1 | −66.2 | 0.30 |
| AHR SRX20282969 | MCF-7 Breast | 100 / 8871 (1.1%) | 3981 / 88710 (4.5%) | −68.1 | −66.2 | 0.25 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 57 / 8871 (0.6%) | 3151 / 88710 (3.6%) | −67.9 | −66.0 | 0.18 |
| FOXA1 SRX219285 | LNCAP Prostate | 205 / 8871 (2.3%) | 5733 / 88710 (6.5%) | −67.8 | −66.0 | 0.36 |
| RELA SRX5938177 | FaDu Others | 201 / 8871 (2.3%) | 5671 / 88710 (6.4%) | −67.8 | −65.9 | 0.35 |
| MECOM SRX23677885 | HNT-34 Blood | 876 / 8871 (9.9%) | 4463 / 88710 (5.0%) | −67.8 | −65.9 | 1.96 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 106 / 8871 (1.2%) | 4082 / 88710 (4.6%) | −67.8 | −65.9 | 0.26 |
| FOXA1 SRX190282 | A549 Lung | 150 / 8871 (1.7%) | 4841 / 88710 (5.5%) | −67.8 | −65.9 | 0.31 |
| FOXA1 SRX1161202 | T-47D Breast | 82 / 8871 (0.9%) | 3640 / 88710 (4.1%) | −67.8 | −65.9 | 0.23 |
| AHR SRX2378695 | MCF-7 Breast | 94 / 8871 (1.1%) | 3865 / 88710 (4.4%) | −67.7 | −65.8 | 0.24 |
| ESR1 SRX5323876 | MCF-7 Breast | 114 / 8871 (1.3%) | 4220 / 88710 (4.8%) | −67.7 | −65.8 | 0.27 |
| NANOG SRX10445309 | Neural crest cells Neural | 114 / 8871 (1.3%) | 4223 / 88710 (4.8%) | −67.7 | −65.8 | 0.27 |
| VGLL1 SRX18013278 | FULVR Breast | 102 / 8871 (1.1%) | 4005 / 88710 (4.5%) | −67.6 | −65.7 | 0.25 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 140 / 8871 (1.6%) | 4671 / 88710 (5.3%) | −67.6 | −65.7 | 0.30 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 814 / 8871 (9.2%) | 4025 / 88710 (4.5%) | −67.6 | −65.7 | 2.02 |
| FOXA1 SRX14612991 | T-47D Breast | 67 / 8871 (0.8%) | 3344 / 88710 (3.8%) | −67.6 | −65.7 | 0.20 |
| ESR1 SRX2513519 | MCF-7 Breast | 119 / 8871 (1.3%) | 4306 / 88710 (4.9%) | −67.6 | −65.7 | 0.28 |
| ESR1 SRX1012631 | MCF-7 Breast | 96 / 8871 (1.1%) | 3891 / 88710 (4.4%) | −67.4 | −65.6 | 0.25 |
| ESR1 SRX5323874 | MCF-7 Breast | 130 / 8871 (1.5%) | 4490 / 88710 (5.1%) | −67.4 | −65.5 | 0.29 |
| ESR1 SRX1012630 | MCF-7 Breast | 82 / 8871 (0.9%) | 3628 / 88710 (4.1%) | −67.3 | −65.4 | 0.23 |
| FOXA1 SRX2642366 | VCaP Prostate | 213 / 8871 (2.4%) | 5832 / 88710 (6.6%) | −67.2 | −65.3 | 0.37 |
| FOXA1 SRX752908 | LNCAP Prostate | 146 / 8871 (1.6%) | 4754 / 88710 (5.4%) | −67.2 | −65.3 | 0.31 |
| SMARCA2 SRX8119677 | MeT-5A Others | 357 / 8871 (4.0%) | 7957 / 88710 (9.0%) | −67.2 | −65.3 | 0.45 |
| FOXA1 SRX1961164 | T-47D Breast | 96 / 8871 (1.1%) | 3877 / 88710 (4.4%) | −67.0 | −65.1 | 0.25 |
| CBX3 SRX6712570 | MCF-7 Breast | 173 / 8871 (2.0%) | 5192 / 88710 (5.9%) | −67.0 | −65.1 | 0.33 |
| CEBPA SRX4705113 | MOLM-13 Blood | 489 / 8871 (5.5%) | 9761 / 88710 (11.0%) | −66.8 | −64.9 | 0.50 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 901 / 8871 (10.2%) | 4670 / 88710 (5.3%) | −66.8 | −64.9 | 1.93 |
| AR SRX1067067 | LHSAR Prostate | 368 / 8871 (4.1%) | 8093 / 88710 (9.1%) | −66.7 | −64.8 | 0.45 |
| FOS SRX4192879 | MCF 10A Breast | 253 / 8871 (2.9%) | 6425 / 88710 (7.2%) | −66.7 | −64.8 | 0.39 |
| ESR1 SRX5534832 | MCF-7 Breast | 200 / 8871 (2.3%) | 5610 / 88710 (6.3%) | −66.7 | −64.8 | 0.36 |
| MAU2 SRX11120892 | MCF-7 Breast | 90 / 8871 (1.0%) | 3759 / 88710 (4.2%) | −66.7 | −64.8 | 0.24 |
| ESR1 SRX20282966 | MCF-7 Breast | 78 / 8871 (0.9%) | 3530 / 88710 (4.0%) | −66.6 | −64.8 | 0.22 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 940 / 8871 (10.6%) | 4962 / 88710 (5.6%) | −66.6 | −64.7 | 1.89 |
| ESR1 SRX7624162 | T-47D Breast | 120 / 8871 (1.4%) | 4288 / 88710 (4.8%) | −66.4 | −64.5 | 0.28 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 159 / 8871 (1.8%) | 4941 / 88710 (5.6%) | −66.4 | −64.5 | 0.32 |
| ESR1 SRX3080213 | MCF-7 Breast | 54 / 8871 (0.6%) | 3042 / 88710 (3.4%) | −66.3 | −64.4 | 0.18 |
| NR3C1 SRX19024870 | MCF-7 Breast | 72 / 8871 (0.8%) | 3405 / 88710 (3.8%) | −66.3 | −64.4 | 0.21 |
| FOXA1 SRX1885181 | LNCAP Prostate | 205 / 8871 (2.3%) | 5677 / 88710 (6.4%) | −66.3 | −64.4 | 0.36 |
| FOXA1 SRX10468633 | Breast cancer cells Breast | 176 / 8871 (2.0%) | 5208 / 88710 (5.9%) | −66.0 | −64.1 | 0.34 |
| TRPS1 SRX3401273 | MCF-7 Breast | 70 / 8871 (0.8%) | 3352 / 88710 (3.8%) | −65.9 | −64.0 | 0.21 |
| ESR1 SRX5089447 | MCF-7 Breast | 102 / 8871 (1.1%) | 3953 / 88710 (4.5%) | −65.9 | −64.0 | 0.26 |
| FOXA2 SRX3322259 | Hep G2 Liver | 139 / 8871 (1.6%) | 4591 / 88710 (5.2%) | −65.9 | −64.0 | 0.30 |
| FOXA1 SRX9604648 | LNCAP Prostate | 283 / 8871 (3.2%) | 6840 / 88710 (7.7%) | −65.8 | −64.0 | 0.41 |
| FOXA1 SRX1885184 | LNCAP Prostate | 209 / 8871 (2.4%) | 5716 / 88710 (6.4%) | −65.6 | −63.8 | 0.37 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 157 / 8871 (1.8%) | 4880 / 88710 (5.5%) | −65.4 | −63.6 | 0.32 |
| ESR1 SRX7624161 | T-47D Breast | 123 / 8871 (1.4%) | 4308 / 88710 (4.9%) | −65.4 | −63.5 | 0.29 |
| FOXA1 SRX9604649 | LNCAP Prostate | 278 / 8871 (3.1%) | 6746 / 88710 (7.6%) | −65.4 | −63.5 | 0.41 |
| FOXA1 SRX1161172 | MCF-7 Breast | 229 / 8871 (2.6%) | 6011 / 88710 (6.8%) | −65.4 | −63.5 | 0.38 |
| FOXA1 SRX10468635 | Breast cancer cells Breast | 190 / 8871 (2.1%) | 5408 / 88710 (6.1%) | −65.4 | −63.5 | 0.35 |
| AR SRX9109109 | MDA-MB-453 Breast | 260 / 8871 (2.9%) | 6476 / 88710 (7.3%) | −65.3 | −63.4 | 0.40 |
| ESR1 SRX2881001 | MCF-7 Breast | 123 / 8871 (1.4%) | 4301 / 88710 (4.8%) | −65.3 | −63.4 | 0.29 |
| ESR1 SRX3110720 | MCF-7 Breast | 91 / 8871 (1.0%) | 3733 / 88710 (4.2%) | −65.3 | −63.4 | 0.24 |
| TET2 SRX8617001 | MCF-7 Breast | 147 / 8871 (1.7%) | 4707 / 88710 (5.3%) | −65.2 | −63.4 | 0.31 |
| FOXA1 SRX18285235 | LNCAP Prostate | 160 / 8871 (1.8%) | 4914 / 88710 (5.5%) | −65.1 | −63.3 | 0.33 |
| PGR SRX3990996 | T-47D Breast | 221 / 8871 (2.5%) | 5874 / 88710 (6.6%) | −64.9 | −63.1 | 0.38 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 59 / 8871 (0.7%) | 3104 / 88710 (3.5%) | −64.9 | −63.0 | 0.19 |
| NKX2-1 SRX2164786 | A549 Lung | 366 / 8871 (4.1%) | 7985 / 88710 (9.0%) | −64.7 | −62.9 | 0.46 |
| FOXA1 SRX1885182 | LNCAP Prostate | 196 / 8871 (2.2%) | 5476 / 88710 (6.2%) | −64.7 | −62.9 | 0.36 |
| ESR1 SRX1469950 | MCF-7 Breast | 82 / 8871 (0.9%) | 3544 / 88710 (4.0%) | −64.6 | −62.8 | 0.23 |
| ESR1 SRX5089450 | MCF-7 Breast | 121 / 8871 (1.4%) | 4248 / 88710 (4.8%) | −64.6 | −62.8 | 0.28 |
| FOXA1 SRX8537736 | MCF-7 Breast | 78 / 8871 (0.9%) | 3466 / 88710 (3.9%) | −64.5 | −62.7 | 0.23 |
| EP300 SRX2194266 | SUM 159PT Breast | 382 / 8871 (4.3%) | 8199 / 88710 (9.2%) | −64.5 | −62.6 | 0.47 |
| ESR1 SRX4451214 | MCF-7 Breast | 195 / 8871 (2.2%) | 5451 / 88710 (6.1%) | −64.4 | −62.6 | 0.36 |
| JUN SRX4192884 | MCF 10A Breast | 191 / 8871 (2.2%) | 5392 / 88710 (6.1%) | −64.4 | −62.6 | 0.35 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 848 / 8871 (9.6%) | 4350 / 88710 (4.9%) | −64.4 | −62.5 | 1.95 |
| FOXA1 SRX142908 | LNCAP Prostate | 122 / 8871 (1.4%) | 4253 / 88710 (4.8%) | −64.3 | −62.5 | 0.29 |
| AR SRX9468664 | LNCAP Prostate | 317 / 8871 (3.6%) | 7267 / 88710 (8.2%) | −64.1 | −62.3 | 0.44 |
| Epitope tags SRX8080552 | Mammary gland ductal carcinoma Breast | 110 / 8871 (1.2%) | 4040 / 88710 (4.6%) | −64.1 | −62.3 | 0.27 |
| NFIL3 SRX2630334 | Hep G2 Liver | 179 / 8871 (2.0%) | 5186 / 88710 (5.8%) | −64.1 | −62.3 | 0.35 |
| ESR1 SRX3123830 | MCF-7 Breast | 63 / 8871 (0.7%) | 3160 / 88710 (3.6%) | −64.1 | −62.2 | 0.20 |
| FOXA1 SRX5323844 | MCF-7 Breast | 63 / 8871 (0.7%) | 3160 / 88710 (3.6%) | −64.1 | −62.2 | 0.20 |
| ARID1A SRX5089380 | MCF-7 Breast | 84 / 8871 (0.9%) | 3565 / 88710 (4.0%) | −64.0 | −62.2 | 0.24 |
| WWTR1 SRX10119367 | MCF 10A Breast | 259 / 8871 (2.9%) | 6413 / 88710 (7.2%) | −64.0 | −62.2 | 0.40 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 182 / 8871 (2.1%) | 5231 / 88710 (5.9%) | −63.9 | −62.1 | 0.35 |
| FOXA1 SRX3931083 | MCF-7 Breast | 135 / 8871 (1.5%) | 4460 / 88710 (5.0%) | −63.9 | −62.1 | 0.30 |
| JUND SRX150408 | HeLa Uterus | 201 / 8871 (2.3%) | 5520 / 88710 (6.2%) | −63.6 | −61.8 | 0.36 |
| ESR1 SRX20282945 | MCF-7 Breast | 59 / 8871 (0.7%) | 3069 / 88710 (3.5%) | −63.6 | −61.8 | 0.19 |
| ESR1 SRX176856 | MCF-7 Breast | 78 / 8871 (0.9%) | 3436 / 88710 (3.9%) | −63.5 | −61.6 | 0.23 |
| FOXA1 SRX5493758 | Breast cancer cells Breast | 161 / 8871 (1.8%) | 4874 / 88710 (5.5%) | −63.5 | −61.6 | 0.33 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 86 / 8871 (1.0%) | 3581 / 88710 (4.0%) | −63.4 | −61.6 | 0.24 |
| FOXA1 SRX3923508 | MCF-7 Breast | 72 / 8871 (0.8%) | 3320 / 88710 (3.7%) | −63.4 | −61.6 | 0.22 |
| EP300 SRX1012649 | MCF-7 Breast | 70 / 8871 (0.8%) | 3276 / 88710 (3.7%) | −63.3 | −61.5 | 0.21 |
| FOXA1 SRX1033292 | LNCAP Prostate | 123 / 8871 (1.4%) | 4235 / 88710 (4.8%) | −63.3 | −61.5 | 0.29 |
Showing first 500 of 25217 rows.